Tech Company Financing Transactions
Neurava Funding Round
Life Science Angels, Elevate Ventures and UCB Ventures participated in a $2.3 million Seed funding round for Neurava. The round closed on 4/5/2024.
Transaction Overview
Company Name
Announced On
4/5/2024
Transaction Type
Venture Equity
Amount
$2,260,000
Round
Seed
Investors
Proceeds Purpose
This funding will allow us to complete a pivotal usability study at leading clinical institutions in adults and pediatric patients with epilepsy. We will also set up manufacturing partners and submit for FDA clearance, in advance of our Series A round of funding.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1220 Waterway Boulevard H105
Indianapolis, IN 46202
USA
Indianapolis, IN 46202
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Wearables To Track Epilepsy; 3.5M people in the US and 65M people worldwide have epilepsy. ~35% of the US population do not respond to anti seizure medications. For as long as their seizures remain uncontrolled, epilepsy patients are at risk of a number of complications, including Sudden Unexpected Death from Epilepsy or SUDEP.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Shah
Chief Technical Officer
Vivek Ganesh
Browse more venture capital transactions:
Prev: 4/5/2024: Archetype AI venture capital transaction
Next: 4/6/2024: Storiaverse venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs